Daiichi-Sankyo (Japan)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
52%
Total
Publications
4.7K
Total Open
Publications
2.4K
Total
Citations
125K
Open Access
Percentage
52%
Total
Publications
4.7K
Total Open
Publications
2.4K
Total
Citations
125K
Breakdown
Publisher Open
28%
Both
19%
Other Platform Open
5%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
468
Hybrid 33%
713
No Guarantees 46%
1K
Other Platform Open
Domain 83%
948
Institution 17%
191
Public 14%
164
Other Internet 6%
70
Preprint 5%
57
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 944 |
Europe PMC | Domain | 479 |
Figshare | Public | 123 |
Semantic Scholar | Public | 119 |
DOI | Other Internet | 89 |
Research Square | Preprint | 33 |
University of Birmingham - University of Birmingham Research Portal | Institution | 31 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 20 |
bioRxiv | Preprint | 15 |
KU Leuven - Lirias | Institution | 14 |